2016
DOI: 10.1016/j.domaniend.2016.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Local immune system in oviduct physiology and pathophysiology: attack or tolerance?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
30
0
3

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(34 citation statements)
references
References 66 publications
1
30
0
3
Order By: Relevance
“…1,37 In contrast, the oviduct activates its innate immunity under pathological conditions such as infection by a pathogen. 1,37 In contrast, the oviduct activates its innate immunity under pathological conditions such as infection by a pathogen.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…1,37 In contrast, the oviduct activates its innate immunity under pathological conditions such as infection by a pathogen. 1,37 In contrast, the oviduct activates its innate immunity under pathological conditions such as infection by a pathogen.…”
Section: Discussionmentioning
confidence: 99%
“…1,37 In contrast, the oviduct activates its innate immunity under pathological conditions such as infection by a pathogen. 37 It has been suggested that neutrophils within the oviduct play a role in phagocytizing sperm by cell-cell attachment or by entrapping them with neutrophil extracellular traps, as well as in protecting them from potentially pathogenic microorganisms. 38 In bovine oviductal tissues, neutrophils exist constantly in stable numbers throughout the estrous cycle.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, extension of infection or inflammation to the oviduct likely disrupts the delicate balance of the immune systems that are required for fertilization (Marey et al, 2016). However, an important observation for mechanisms that perturb fertility, is that postpartum uterine infection also impacts fertility after resolution of the clinical disease (Borsberry and Dobson, 1989).…”
Section: Impact Of Uterine Disease On Animal Health and Fertilitymentioning
confidence: 99%
“…Besides parameters used in general toxicity studies, assessment of tissue toxicity may be an assumable minimum consensus, and other Special toxicity studies and cell-based medicinal products: Special toxicity studies required for low-molecular weight compounds include carcinogenicity studies; antigenicity studies; genotoxicity studies; reproductive and developmental toxicity studies; and, if appropriate, local tolerance studies, dependence studies, and photo toxicity studies [10][11][12]. Carcinogenicity studies of chemical compounds are to be conducted if (1) the results of genotoxicity studies suggest a concern about carcinogenic potential, (2) a possible risk of cancer in humans has previously been indicated, (3) the structure-activity relationship suggests genotoxic and/or carcinogenic potential, (4) repeated-dose toxicity studies provide evidence of paraneoplastic changes, and/or (5) the parent compound or its metabolite(s) remain in the tissue for a long time, possibly resulting in local histological or pathological changes.…”
Section: Translational Medicinementioning
confidence: 99%